Additionally Canada had four IPOs in 2004 with rounds ranging from $12.3 million to $42.4 million. These generated a total of $85 million in IPO financing that year. In total Canadian biotech companies raised about $520 million in 2004 versus $1.1 billion in 2003. Some of Canadas leading biotech companies include: Bioavail ID Biomedical Angiotech Pharmaceuticals QLT